BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9687884)

  • 1. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
    Ghosh P; Bag SP; Sur B; Sur P
    Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
    Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
    Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour.
    Sur P; Ghosh P; Bag SP; Sur B; Chatterjee SN
    Chemotherapy; 1999; 45(5):360-9. PubMed ID: 10473924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
    Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
    Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
    Ghosh P; Sur B; Bag SP; Sur P
    Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
    Shenoy BD; Udupa N; Kamath R; Devi PU
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
    Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
    Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of cytostatic folic acid antagonists 1-(3,4-dichlorophenyl)-5-isopropyl-biguanide and its boron compounds.
    Bollag W
    Experientia; 1968 Oct; 24(10):1049-50. PubMed ID: 5304711
    [No Abstract]   [Full Text] [Related]  

  • 10. Regioselective one-pot synthesis and anti-proliferative and apoptotic effects of some novel tetrazolo[1,5-a]pyrimidine derivatives.
    Hussein AM; Ahmed OM
    Bioorg Med Chem; 2010 Apr; 18(7):2639-44. PubMed ID: 20227281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
    El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
    Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Socaciu C; Bara A; Silvestru C; Haiduc I
    In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
    Nersesyan A; Muradyan R; Arsenyan F
    J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A modification of the toxic effects of platinum complexes with antocyans].
    Karaivanova M; Drenska D; Ovcharov R
    Eksp Med Morfol; 1990; 29(2):19-24. PubMed ID: 2073882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antitumor effects of a new boron compound combined with ultrasound on the mouse ascites tumor.
    Ghosh P; Sur P; Bag SP
    Med Chem; 2012 Nov; 8(6):1026-31. PubMed ID: 22779757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of some esters of 4-hydroxy-5-nitro-4,5-dihydrothymine on the growth of tumor cells.
    Comes R; Postescu ID; Mustea I
    Pharmazie; 1982 Apr; 37(4):283-5. PubMed ID: 7100253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
    Xie QJ; Zhang X; Wang X; Bai L; Li HY
    Zhong Yao Cai; 2009 Jun; 32(6):933-6. PubMed ID: 19764334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
    Sanyal U; Dutta S; Das H
    Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.
    Wu H; Micca PL; Makar MS; Miura M
    Bioorg Med Chem; 2006 Aug; 14(15):5083-92. PubMed ID: 16651000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.